OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis
Theresa Ryckman, Samuel G. Schumacher, Christian Lienhardt, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 6, pp. e995-e1004
Open Access | Times Cited: 7
Theresa Ryckman, Samuel G. Schumacher, Christian Lienhardt, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 6, pp. e995-e1004
Open Access | Times Cited: 7
Showing 7 citing articles:
Global, regional, and national burden of HIV-negative tuberculosis, 1990–2021: findings from the Global Burden of Disease Study 2021
Shun-Xian Zhang, Fengyu Miao, Jian Yang, et al.
Infectious Diseases of Poverty (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Shun-Xian Zhang, Fengyu Miao, Jian Yang, et al.
Infectious Diseases of Poverty (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and Scientists
Christoph Lange, Graham Bothamley, Gunar Günther, et al.
Pathogens and Immunity (2025) Vol. 10, Iss. 2, pp. 1-45
Open Access
Christoph Lange, Graham Bothamley, Gunar Günther, et al.
Pathogens and Immunity (2025) Vol. 10, Iss. 2, pp. 1-45
Open Access
Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance
Christopher Finn McQuaid, Theresa Ryckman, Nicolas A. Menzies, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 8
Open Access | Times Cited: 3
Christopher Finn McQuaid, Theresa Ryckman, Nicolas A. Menzies, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 8
Open Access | Times Cited: 3
Projected health and economic effects of a pan-tuberculosis treatment regimen: a modelling study
Theresa Ryckman, Christopher Finn McQuaid, Ted Cohen, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 10, pp. e1629-e1637
Open Access | Times Cited: 3
Theresa Ryckman, Christopher Finn McQuaid, Ted Cohen, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 10, pp. e1629-e1637
Open Access | Times Cited: 3
Global, regional, and national burden of HIV-negative tuberculosis, 1990–2021: Findings from the Global Burden of Disease 2021 Study
Shun-Xian Zhang, Fengyu Miao, Jian Yang, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Shun-Xian Zhang, Fengyu Miao, Jian Yang, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Economic aspects of shortening the duration of tuberculosis treatment
Malaisamy Muniyandi, Karikalan Nagarajan
The Lancet Global Health (2024) Vol. 12, Iss. 6, pp. e901-e902
Closed Access
Malaisamy Muniyandi, Karikalan Nagarajan
The Lancet Global Health (2024) Vol. 12, Iss. 6, pp. e901-e902
Closed Access
Current challenges and future development of India’s healthcare system’ towards tuberculosis free India – research evidence and programmatic initiatives
Gopalan Narendran, Ariarathinam Newtonraj, Luke Elizabeth Hanna, et al.
(2024) Vol. 1, Iss. 1, pp. 35-58
Closed Access
Gopalan Narendran, Ariarathinam Newtonraj, Luke Elizabeth Hanna, et al.
(2024) Vol. 1, Iss. 1, pp. 35-58
Closed Access
